The LMNA gene encodes lamin A/C intermediate filaments that polymerize beneath the nuclear membrane, and are also found in the nucleoplasm in an uncharacterized assembly state. They are thought to have structural functions and regulatory roles in signaling pathways via interaction with transcription factors. Mutations in LMNA have been involved in numerous inherited human diseases, including severe congenital muscular dystrophy (L-CMD). We created the Lmna DK32 knock-in mouse harboring a L-CMD mutation. Lmna DK32/DK32 mice exhibited striated muscle maturation delay and metabolic defects, including reduced adipose tissue and hypoglycemia leading to premature death. The level of mutant proteins was markedly lower in Lmna DK32/DK32 , and while wild-type lamin A/C proteins were progressively relocated from nucleoplasmic foci to the nuclear rim during embryonic development, mutant proteins were maintained in nucleoplasmic foci. In the liver and during adipocyte differentiation, expression of DK32-lamin A/C altered sterol regulatory element binding protein 1 (SREBP-1) transcriptional activities. Taken together, our results suggest that lamin A/C relocation at the nuclear lamina seems important for tissue maturation potentially by releasing its inhibitory function on transcriptional factors, including but not restricted to SREBP-1. And importantly, L-CMD patients should be investigated for putative metabolic disorders.
INTRODUCTION
A-and B-type lamins are the major constituents of the nuclear lamina, a meshwork of proteins underlying the inner nuclear membrane (1) . B-type lamins comprising lamins B1 and B2 are encoded by the LMNB1 and LMNB2 genes, respectively, while A-type lamins mainly comprising lamin A and lamin C are encoded by the LMNA gene. Lamin A is synthesized in an immature form, the prelamin A, which undergoes several post-translational modifications to produce the † Present address: Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. * To whom correspondence should be addressed at: Thérapie des maladies du muscle strié/Inserm U974, UPMC UM76, CNRS UMR7215, Institut de Myologie, G.H. Pitié-Salpêtrière, 47 boulevard de l'Hôpital, F-75 651 Paris Cedex 13, France. Tel: +33 142165723; Fax: +33 142165700; Email: g.bonne@institut-myologie.org mature lamin A. Lamins A and C (henceforth referred to as lamin A/C) dimerize and further assemble to form head-to-tail polar polymers which finally associate laterally and eventually form lamin filaments that, together with lamin B filaments, constitute the nuclear lamina (2) . Lamin A/C is also found in the nucleoplasm in a still unknown assembly state and may have multiple functions by associating with chromatin, nuclear histones and various transcription factors (1) .
Recent interest in LMNA has centered on the finding that mutations in this gene give rise to more than 10 distinct genetic diseases, commonly named laminopathies. The first LMNA mutation was identified in autosomal dominant Emery -Dreifuss muscular dystrophy (EDMD) (3) . Since then, mutations in LMNA have been shown to be associated to disorders with a systemic involvement (and referred to as premature ageing syndromes) or affecting tissues in a specific manner [disorders affecting the adipose tissue like familial partial lipodystrophy (FPLD), the nerve or the striated muscles] (1,4). Among laminopathies affecting striated muscles, we recently described the LMNA-related congenital muscular dystrophy (L-CMD), which represents the most severe form of muscular involvement among laminopathies with uncertain heart involvement to date (5) .
While the correlation between accumulation of prelamin A and premature ageing syndromes or lipodystrophies are clear (6, 7) , the relationship between LMNA mutations and other laminopathies is far from being understood, particularly in laminopathies affecting striated muscles. To date, two hypotheses have been proposed that are not mutually exclusive (reviewed in 1,4). (i) The structural hypothesis is based on the role of lamins and associated proteins such as the linker of nucleoskeleton and cytoskeleton (LINC) complex proteins Nesprins and SUN, in maintaining the mechanical integrity of cells by linking the nucleoskeleton to the cytoskeleton (8) . A 'weakened' lamina would lead to overall loss of the cell's ability to withstand stress-induced damage, which may be of critical significance in contractile tissues such as skeletal and cardiac muscles (9) . (ii) The gene expression hypothesis is based on the role of lamins in transcription and cell signaling via their interactions with chromatin, histone or TATAbinding protein (TBP) (10, 11) and with transcription factors such as retinoblastoma (Rb) or sterol regulatory element binding protein 1 (SREBP-1) (12, 13) .
In the present paper, we reproduce in mice by homologous recombination a LMNA mutation identified in patients with severe EDMD or L-CMD (5, 14) . The LMNA p.delK32 mutation corresponds to the deletion of the lysine in position 32, in the N-terminal domain of lamin A/C involved in the lateral assembly of head to tail polymers of lamin A/C (15, 16) . Whereas wild-type (WT) lamin A/C was able to relocate from the nucleoplasm to the nuclear periphery during embryonic development, DK32-lamin A/C mutant proteins were unable to assemble at the nuclear lamina and remained in nucleoplasmic foci in Lmna DK32/DK32 mouse tissues. In addition, despite low steady-state levels of mutant lamins, toxic effects on mouse physiology were observed: Lmna DK32/DK32 mice have major growth retardation associated with skeletal and cardiac muscle maturation defects. They died during the third week of life from severe metabolic defects probably due at least in part to a repressive action of mutant lamins on SREBP-1 transcriptional activities, which resulted in the alteration of adipose tissue differentiation and glucose homeostasis. Overall, these results demonstrate the crucial role of the N-terminal domain of lamin A/C for their polymerization and the regulation of transcription factor's activities. Finally, results obtained on Lmna DK32/DK32 mice suggest that L-CMD patients should be investigated for putative metabolic disorders that have remained unexplored so far.
RESULTS

Impact of delK32 mutation on lamin A/C expression and localization
Considering the localization of the DK32 mutation in a domain of lamin A/C involved in their polymerization (15, 16) , we hypothesized that this mutation could have a strong impact on lamin A/C organization. Hence, we investigated the cellular localization of A-type lamins in different mouse tissues and at different stages of embryonic and postnatal development. By immunostaining of embryo sections at embryonic day 12.5 (E12.5), WT and DK32-lamin A/C were both found as multiple foci in the nucleoplasm (Fig. 1A) . At E17.5, WT lamin A/C was progressively relocalized at the nuclear periphery, while DK32-lamin A/C was not (Fig. 1B) . A similar localization was observed in postnatal muscles, with a strong lamin A/C staining at the nuclear periphery in Lmna +/+ and a weak staining in nuclear foci in Lmna DK32/DK32 muscles (Fig. 1C) . In postnatal Lmna
muscles, lamin A/C was observed at the nuclear rim, as observed for WT muscle, although the signal was fainter. Similar results were obtained in all tissues tested in postnatal mice, although the lamin A/C perinuclear staining was more pronounced in post-mitotic nuclei, such as myonuclei (tibialis anterior, quadriceps and soleus muscles and heart, data not shown). In contrast to lamin A/C, lamin B1 was always observed at the nuclear periphery in WT and Lmna DK32/DK32 mice ( Fig. 1A and B) . Overall, these data suggest that mutant DK32-lamin A/C is not able to assemble in the nuclear lamina of Lmna DK32/DK32 cells. The level of the lamin A/C protein was 50 and 80% lower in Lmna +/DK32 and Lmna DK32/DK32 skeletal muscles, respectively (Fig. 1D) , as in all analyzed tissues, compared with Lmna +/+ mice. Prelamin A was not detected (data not shown) and lamin B1 expression level was unaffected (Fig. 1D) . Interestingly, the level of lamin A/C mRNA did not differ in the tissues of the three genotypes (data not shown), suggesting that lower steady-state level of mutant proteins results from reduced translation efficiency or higher rate of protein degradation. mice showed a severe reduction in the growth curve (Fig. 1E) . By P12, they were 50% lighter (Fig. 1E ) and significantly smaller (Fig. 1F ) than their littermates, and they irremediably started to lose weight and die. By P15, only half of Lmna DK32/ DK32 mice were still alive, and by P19, they were all dead (Fig. 1G) . Experimental observation of several litters revealed that young Lmna DK32/DK32 mice had a slight delay in walk acquisition compared with Lmna +/+ and Lmna +/DK32 littermates. Once normal gait was acquired, Lmna DK32/DK32 mice rapidly displayed a waddling gait that evolved into an increasing number of falls apparently due to hindquarter blockade.
Defective skeletal muscle maturation
Histological analysis of skeletal muscle of Lmna DK32/DK32 mice at birth revealed that all skeletal muscles analyzed were already affected and showed a reduction in fiber size compared with Lmna +/+ and Lmna +/DK32 muscles (data not shown). A reduction in skeletal muscle fiber crosssectional area in Lmna DK32/DK32 was also observed at P14 as shown for the gastrocnemius muscle ( Fig. 2A and B) . This was associated with the persistence of centralized myonuclei at all time points analyzed (P5, P8 and P14) ( Fig. 2A, white arrows) . Quantification performed at P14 in the gastrocnemii revealed a significant increase in the number of central nuclei in Lmna DK32/DK32 (Fig. 2C ). This was not linked to repeated cycles of muscle necrosis/regeneration as inflammation, necrotic features or fibrosis were never observed.
Reduced muscle fiber cross-sectional area and increased number of central nuclei without signs of regeneration may be associated to an immature muscle phenotype. Consequently, we then looked at the switch from the two developmental myosin heavy chains, the embryonic (MyHC-emb, encoded by the Myh3 gene) and the neonatal (MyHC-neo, encoded by the Myh8 gene) myosin heavy chains to adult fast-and slow-myosin heavy chains in P14 gastrocnemius sections. While Lmna +/+ mice had almost completely switch off their MyHC-emb expression to express adult fast and slow-twitch myosins, the Lmna DK32/ DK32 still expressed significant levels of MyHC-emb. Lmna +/ DK32 mice have an intermediate phenotype (Fig. 2D ). Muscle fibers with MyHC-neo expression were never observed in the three genotypes in P14 gastrocnemii. Overall, these results suggest that Lmna DK32/DK32 mice exhibit a defect in muscle maturation.
Cardiac maturation defects
We then investigated whether Lmna DK32/DK32 mice developed a cardiac phenotype. The heart weight to tibia length ratio was significantly and markedly lower in P14 but not in newborn (P0) Lmna DK32/DK32 compared with Lmna +/+ and Lmna
mice (Fig. 3A) . Lmna DK32/DK32 hearts did not show signs of ventricular hypertrophy or dilatation (Fig. 3B ). On the other hand, the number of lipid droplets remained high in cardiomyocytes of P14-Lmna DK32/DK32 (Fig. 3C ), whereas they almost completely disappeared as soon as P5 in Lmna
and Lmna +/DK32 cardiomyocytes. Similar to what was observed in skeletal muscles, cardiomyocyte cross-sectional area was markedly smaller in Lmna DK32/DK32 (Fig. 3D ). To further analyze the heart, we performed echocardiographic analysis on 2-week-old mice. This analysis confirmed the lower heart weight in Lmna DK32/DK32 than in Lmna +/+ and Lmna +/DK32 littermates (Supplementary Material, Table S1 ). However, no sign of cardiac hypertrophy, dilation or dysfunction was revealed. Finally, to discriminate between cardiac remodeling and cardiac immaturity, we determined the expression of genes that are differently regulated during these two processes: the natriuretic peptide precursor A and B genes (Nppa and Nppb), the alkali and regulatory myosin light chain genes (Myl4 and Myl7) (17) and a-and b-myosin heavy chain genes (Myh6 and Myh7): a strong expression of Nppa, Nppb and Myh7 without overexpression of Myl4 and Myl7 being a characteristic of embryonic hearts, while overexpression of Nppa, Nppb, Myh7, Myl4 and Myl7 is associated to cardiac remodeling (18) . In Lmna DK32/DK32 hearts, we found an increase in Nppa, Nppb and Myh7 mRNA levels and a decrease in Myh6 mRNA levels compared with Lmna +/+ and Lmna +/DK32 hearts (Fig. 3E ). Myl4 and Myl7 mRNA levels did not differ between the three genotypes. Altogether, these data suggest a cardiac maturation defect without incidence on cardiac remodeling or function in Lmna DK32/DK32
.
Metabolic defects
In addition to the skeletal and cardiac muscle defects, standard systematic phenotyping also revealed a marked reduction or even an absence of white adipose tissue (WAT) in and Lmna DK32/DK32 gastrocnemius sections (scale bar: 50 mm). (B) Cross-sectional area (csa) repartition from Lmna (Fig. 4B ). Insulin plasma level was also much lower, suggesting that Lmna DK32/DK32 mice are not insulino-resistant (Fig. 4C ). As severe hypoglycemia may result from defects in b-oxidation, acylcarnitine levels were measured in the urine of the mice. C2-and C6-acylcarnitine levels were higher, whereas others (C8, C10 and C12 chains) exhibited only a trend toward higher content in Lmna DK32/DK32 than in Lmna +/+ and Lmna +/DK32 mice (Table 1) . Hence, these data suggest that (i) b-oxidation is not altered, and (ii) ketogenesis is an active phenomenon in Lmna DK32/DK32 mice.
Implication of SREBP-1 transcription factor
SREBP-1 transcription factor plays a key role in energy homeostasis by regulating lipogenesis via expression of enzymes involved in glucose utilization and fatty-acid synthesis, such as acetyl-CoA carboxylase or fatty-acid synthase (19, 20) . Moreover, SREBP-1 is also involved in adipocyte determination and differentiation via expression of PPARg (21) . Interestingly, SREBP-1 interacts with lamin A (13). Hence, we hypothesized that a defect in the SREBP-1 pathway may be involved in the metabolic defects in Lmna DK32/DK32 mice. To test this hypothesis, we evaluated the level of the SREBP-1 protein in 14-day-old mouse liver. Both the precursor (125 kDa) and the mature (68 kDa) forms of SREBP-1 were present in Lmna +/+ and Lmna +/DK32 (Fig. 5A ), whereas only the mature form was detected in Lmna DK32/ Figure 3 . DK32-lamin A/C is responsible for defects in postnatal maturation of cardiac muscle. (A) Heart weight to tibia length ratio (HW/TL) at birth (P0) and at P14 Lmna +/+ (n ¼ 3 and n ¼ 27, respectively; in black), Lmna +/DK32 (n ¼ 2 and n ¼ 28; respectively; in grey) and Lmna DK32/DK32 (n ¼ 2 and n ¼ 36; respectively; in white) mice measured in mg/cm (data are represented as mean + SD). *** P ≤ 0.001 between Lmna +/+ and Lmna DK32/DK32 ; $$$P ≤ 0.001 between Lmna +/DK32 and Lmna DK32/DK32 . (B) Hematoxylin/eosin (HE) staining of cardiac section at P11 in Lmna +/+ , Lmna +/DK32 and Lmna DK32/DK32 mice (scale bar: 1 mm). (C) Oil Red O (ORO) staining of Lmna +/+ , Lmna +/DK32 and Lmna DK32/DK32 heart sections, counterstained with HE (scale bar: 20 mm). (D) Cross-sectional area (csa) of cardiomyocytes in Lmna +/+ (n ¼ 3; in black), Lmna +/DK32 (n ¼ 3; in grey) and Lmna DK32/DK32 (n ¼ 3; in white) hearts. (E) Quantitative polymerase chain reaction (PCR) analysis of Nppa, Nppb, Myl4, Myl7, Myh6 and Myh7 mRNA relative to Rplp0 mRNA presented as the mean + SD of triplicate of Lmna +/+ (n ¼ 7; in black), Lmna +/DK32 (n ¼ 7; in grey) and Lmna DK32/DK32 (n ¼ 4; in white) hearts, with * , ** and *** corresponding to P ≤ 0.05, P ≤ 0.01 and P ≤ 0.001 between Lmna +/+ and Lmna DK32/DK32 , respectively, and $, $$ and $$$ corresponding to P ≤ 0.05, P ≤ 0.01 and P ≤ 0.001 between Lmna +/DK32 and Lmna DK32/DK32 , respectively. See also Supplementary Material, Table S1 .
DK32 liver. Overall, the levels of the SREBP-1 protein (precursor and mature forms) were lower in Lmna DK32/DK32 mouse liver. We then evaluated the ability of mature SREBP-1 to translocate in the nucleus of hepatocytes by immunostaining on liver sections. A strong signal for SREBP-1 was observed in Lmna +/+ and Lmna DK32/DK32 nuclei suggesting normal nuclear translocation (Fig. 5B) .
To evaluate whether the lower levels of the SREBP-1 protein resulted from lower transcription efficiency in Lmna DK32/DK32 mice, expression of the Srebf1 gene (encoding SREBP-1) was determined at the mRNA level. Srebf1 mRNA level was markedly lower in Lmna DK32/DK32 liver (Fig. 5C ). Interestingly, it has been shown that SREBP-1 directly targets its own expression. Hence, we suspected that mutant lamin A/C impedes the capacity of SREBP-1 to correctly activate the transcription of its target genes in Lmna DK32/DK32 mice. Therefore, we evaluated expression of SREBP-1 target genes, Acc2 and Fas as well as Peroxisome proliferator activated receptors (Ppara, Ppard and Pparg encoding PPARa, PPARb/d and PPARg, respectively), PPARa being the major PPAR isoform expressed in the liver (22) . Fas, Ppara and Ppard mRNA levels, but not Acc2 and Pparg, were markedly lower in Lmna DK32/DK32 than in Lmna +/+ and Lmna
livers (Fig. 5C ). These data suggest that mutant lamin A/C has a dominant-negative effect on SREBP-1 transcriptional activity in the liver. Considering the major role of SREBP-1 in promoting WAT differentiation, the reduction in WAT in Lmna DK32/DK32 may also be related to the transcriptional inhibition of SREBP-1 in the presence of DK32-lamin A/C mutant. We therefore . Table 1 . Acylcarnitine quantification and Lmna DK32/DK32 mouse embryonic fibroblasts (MEFs). Similar to in vivo data, lamin A/C was correctly localized mainly at the nuclear periphery in WT MEFs, while DK32-lamin was only observed in the nucleoplasm (Fig. 5D) . By days 8 and 10 after induction of adipogenic differentiation, almost all Lmna +/+ MEFs exhibited nuclear expression of PPARg, while none of Lmna DK32/DK32 MEFs 
(B) Indirect immunofluorescent confocal micrographs of Lmna
+/+ and Lmna DK32/DK32 liver sections stained for SREBP-1 (in red) and lamin A/C (in green) (scale bar: 20 mm). (C) Quantitative PCR analysis for Srebf1, Acc2, Fas, Ppara, Ppard and Pparg mRNA expression relative to Rplp0 mRNA levels in P14 Lmna +/+ (n ¼ 6; in black), Lmna +/DK32 (n ¼ 6; in grey) and Lmna DK32/DK32 (n ¼ 6; in white) liver represented as mean + SD; with * corresponding to P ≤ 0.05 between Lmna +/+ and Lmna DK32/DK32 and $ for P ≤ 0.05 between Lmna +/DK32 and Lmna did (Fig. 5D) . Moreover, by day 10 after induction of adipogenic differentiation, Lmna +/+ MEFs have accumulated numerous lipid droplets in their cytoplasm as judged by Oil Red O staining, while Lmna DK32/DK32 MEFs have not (Fig. 5E ). These results suggest that adipocyte differentiation is strongly altered in Lmna DK32/DK32 mice.
DISCUSSION
In this study, we tested in mice the impact of a mutation of the LMNA gene responsible for severe EDMD or L-CMD in patients. Through the generation of an Lmna
DK32/DK32
knock-in mouse, we showed the inability of mutant lamin A/C to assemble at the nuclear lamina, while this translocation happened during embryogenesis in Lmna +/+ mice. Moreover, we observed lower level of lamin A/C protein, but not of the mRNA in Lmna +/DK32 and Lmna DK32/DK32 mice, suggesting that a reduced translation efficiency or higher rate of degradation of mutant lamin A/C. The markedly lower level of lamin A/C, the absence of nuclear lamina formation and the persistence of mutated lamin A/C in the nucleoplasm of Lmna DK32/DK32 cells likely all contribute to the development of a severe phenotype. It includes maturation delay of skeletal and cardiac muscles relevant to the human disorders, as well as unsuspected metabolic defects involving alteration of SREBP-1 transcriptional activity in the liver and WAT, and responsible for general energetic exhaustion and premature death of Lmna DK32/DK32 mice during the third week of life. Overall, our data suggest that lamin A/C location at the nuclear rim seems essential for tissue maturation, most probably by releasing its inhibitory function on transcriptional factors in the nucleoplasm. Moreover, our findings suggest that metabolic disorders may also contribute to the severity of the phenotype in patients, a finding that warrant further explorations in clinics.
Maturation defects in Lmna
DK32/DK32 mice Analysis of Lmna DK32/DK32 mice revealed a defect in the maturation of skeletal muscles, heart and WAT. It has been previously shown that the expression of MyHC-emb and MyHC-neo was progressively replaced by expression of adult MyHC-fast and -slow during the second and third postnatal weeks in mouse (23) . Expression of MyHC-emb (and not of MyHC-neo) in our 14-day-old WT muscles may be due to differences in mouse genetic background compared with the mouse used in Agbulut's study. However, the concomitant presence of MyHC-emb-positive fibers with increased central nuclei and reduced fiber crosssectional area in the absence of fibrosis and of any signs of necrosis/regeneration 2 weeks after birth in Lmna DK32/DK32 mouse muscles strongly suggest a defect in muscle maturation. Very similar observations have been reported in some L-CMD patients, with the presence of muscle fibers expressing neonatal myosin isoforms (5) . In the heart, one of the main changes during the post-natal period is the switch in energy source from glucose towards fatty acids (24, 25) . Together with PGC-1a, PPARa has been shown to be the main trigger of this shift, by activating expression of genes involved in fatty-acid oxidation (FAO) (24) . In Lmna DK32/DK32 hearts, we have shown that, in addition to an immature transcriptional fingerprint and a decreased heart growth, a high proportion of intracardiac lipid droplets remained. This suggests that a defect of FAO enzymes needed to use fatty acid as energy source might play a role in the persistence of intracardiac lipid droplets. Finally, we showed that Lmna DK32/DK32 mice have poorly differentiated WAT. As PPARg is the main transcription factor involved in adipogenesis (26) , the absence of PPARg expression in Lmna DK32/DK32 MEFs induced to differentiate in adipocytes is probably involved in the immature state of WAT in 2-week-old Lmna DK32/DK32 mice.
Impact of reduced lamin A/C expression and dominant-negative effect of the mutation
Two Lmna knock-out mouse models have been described with a relatively similar phenotype to Lmna DK32/DK32 mice, suggesting that reduced lamin A/C level is partially responsible for the phenotype in our mouse model. Indeed, Lmna 2/2 or Lmna GT2/2 mice presented with growth retardation, skeletal and cardiac muscle involvement, hypoglycemia, reduced WAT and premature death (27) (28) (29) . However, the phenotype was much more dramatic in Lmna DK32/DK32 mice. Interestingly, insulin levels were not different between WT and Lmna 2/2 mice at 4 weeks (28), while it was already significantly lower at 2 weeks in our Lmna DK32/DK32 mice. Moreover, Lmna GT2/2 skeletal and cardiac muscles did show impaired post-natal growth but no maturation defects (29) . Overall, it suggests that in addition to an effect due to the decreased lamin A/C expression, DK32-lamin mutants exert a toxic function on tissue maturation. This study shows, for the first time, changes in lamin A/C organization during normal embryonic development, with the progressive disappearance of the nuclear foci in muscle around birth. The dominant-negative effect of mutant DK32-lamin may be due to their persistence in nucleoplasmic foci in postnatal mice, maintaining cells in an immature state. Modifications of lamin A/C organization have been reported during adipogenesis (30) . Similarly, lamin A/C relocation from nuclear foci to the nuclear periphery has been described during in vitro myoblast differentiation (31) (32) (33) . In these myoblasts, lamin A/C localized in foci was shown to interact with protein complexes, including Rb protein involved in cell cycle exit, and the interaction was lost upon lamin A/C relocation under the nuclear membrane.
Interestingly, in Coenorhabditis elegans, the △K46-Ce lamin mutation (corresponding to DK32-lamin mutation in mammals) was recently reported to cause lateral polymerization defects in vitro, leading in vivo to aggregates formation containing other proteins and to a muscle phenotype (16) . RNAi targeting to Ce-lamin in the mutant worms rescues the muscle phenotype, clearly demonstrating the dominantnegative effect of △K46-Ce lamin. A similar polymerization defect may occur in Lmna DK32/DK32 nuclei, leading to the absence of lamin A/C at the nuclear lamina and the sequestration of proteins inside the foci.
Implication of SREBP-1
Part of the pathogenesis could be attributed to the defective SREBP-1 pathway in Lmna DK32/DK32 mice. SREBP-1 exerts its action through the transcriptional activation of genes involved in adipogenic differentiation such as Pparg (34) and genes involved in lipid metabolism like Lpl, Acc or Fas (21,35,36) . In Lmna DK32/DK32 mice, SREBP-1 was not able to induce the expression of Ppara, Ppard and Fas in the liver. Similarly, we showed that Lmna DK32/DK32 MEF cells induced to differentiate into adipocytes were unable to activate PPARg expression and did not accumulate lipid droplets and thus have defective adipogenesis. Altogether, it is conceivable that Lmna DK32/DK32 mice develop hypoglycemia because of their defective fatty-acid storage in liver and WAT. In such condition, ketogenesis, indirectly observed by increased urinary C2-acylcarnitine in Lmna DK32/DK32 (37), may reflect the normal hepatic reaction to decreased glucose levels in a prolonged fasting state. Nevertheless, the observed decrease in plasma levels of glucose in spite of active ketogenesis suggests that neoglucogenesis may be impaired, possibly because of the cachectic state of Lmna DK32/DK32 mice. Indeed, when lipids are depleted, amino acid metabolism, a source of Krebs cycle intermediates and of keto bodies, may provide insufficient energy to carry out neoglucogenesis in the liver. The resulting glucose depletion impairs Krebs cycle function and keto body metabolism in the peripheric tissues, thus reinforcing ketosis. Overall, we suggest that general exhaustion is the primary cause of death in Lmna DK32/DK32 mice. However, alteration of SREBP-1 transcriptional activity is probably not responsible for all of the observed Lmna DK32/DK32 defects. In skeletal muscle, activation of the SREBP-1 pathway has been recently implicated in muscle differentiation defect and atrophy (38) . Hence, alteration of SREBP-1 signaling in skeletal muscle would probably be involved in muscle hypertrophy. Therefore, we think that SREBP-1 defect is probably not implicated in muscle maturation defect observed in Lmna DK32/D32
. Inhibition of other transcription factors, such as Rb, might be implicated in the Lmna DK32/D32 mouse phenotype. Rb has major functions in myogenesis and cardiogenesis (39) , and interaction between lamins A/C and Rb has been previously described (40) . Interestingly, defective Rb signaling in skeletal muscles has already been reported in Lmna 2/2 mice or lamin mutant fibroblasts (32, 41) . Moreover, Rb is also implicated in adipocyte differentiation towards the white lineage instead of the brown lineage (42) , and Rb 2/2 MEFs are unable to undergo adipose conversion (43) . Additionally, mislocalization of DN-lamin A proteins in nucleoplasmic aggregates, highly similar to DK32-lamin A/ C, has been involved in inhibition of RNA polymerase II activity via sequestration of TBP in DN-lamin A-containing aggregates (11) . In transfected cells and in FPLD-mutant cells, transcription is altered as judged by BrU incorporation (6, 11) . Finally, our findings do not exclude that the absence of lamin A/C at the nuclear lamina is also responsible for defective interactions with known partners at the nuclear envelope, such as emerin, LINC complex proteins and other LAP2-Emerin-MAN1 proteins, which increases nuclear fragility (1, 8) .
Altogether, we propose that the relocation of WT lamin A/C from the nucleoplasm to the nuclear periphery is important for proper maturation of organs. In cells expressing DK32-lamin A/C proteins, defective for lateral assembly and hence for polymerization at the nuclear lamina, the absence of lamin A/C relocation associated with dominant-negative action of DK32-lamin A/C inside the nucleoplasm is responsible for maturation defects. Thus, we suppose that EDMD and L-CMD patients harboring LMNA p.delK32 mutation or LMNA mutations leading to abnormal polymerization also have metabolic defects that may contribute to the severity of their phenotype. Therefore, our data emphasize the importance to investigate metabolic defects in severe forms of LMNA-related muscular dystrophies.
MATERIALS AND METHODS
Mice
Homologous recombination vector was obtained by cleaving the mouse bacterial artificial chromosome-containing Lmna exon 1 and intron 1 with NsiI into pGEM-T Easy. The deletion of lysine 32 (delAAG) was introduced in exon 1 by the polymerase chain reaction (PCR) mutagenesis method, while the XhoI restriction site was added in intron 1. The floxed Neomycin-Cre recombinase cassette (from pACN vector) and the thymidine kinase cassette (from pMCI-TK vector) were subsequently cloned into XhoI and SalI of Lmna exon 1 -intron 1 -pGEM-T, respectively. NsiI linearized vector was injected into 129/SvJ embryonic stem cells. Homologous recombination was checked by neomycin resistance and gancyclovir sensitivity. Recombined ES cells were analyzed by Southern blot and positive ones were injected in C57BL/6 blastocysts to give chimera. Chimeric mice were crossed onto C57BL/6 mice and resulted progeny were genotyped for germline transmission using the following primers F2:
It is important to note that the system used leads to the deletion of the neomycin-Cre cassette from the DNA during the spermatogenesis (44) . The Lmna DelK32 mouse model was produced on CIPHE IBiSA platform, Marseille.
Systematic standard phenotype evaluation was performed at Institute Clinique de la Souris (Illkirch, France), which comprises macroscopic and morphological evaluation of 40 organs (for complete protocol see http://www.ics-mci.fr/dep _phenotyping_services.html). Except when mentioned, experiments were performed on P14 mice with same age inside a specific experiment. Mice were euthanized by intraperitoneal injection of overdose anesthetics (ketamine:xylasine:saline 1/ 1/1; 6.5 ml/g) before tissue excision. Experimental procedures on animals were performed in accordance with European legislation (L358-86/609/EEC).
Cells and adipogenic differentiation
Mouse embryos were carefully collected at E13.5 of Lmna +/+ and Lmna DK32/DK32 embryos. After dissection of head and visceral organs for genotyping, embryos were minced and trypsinised for 30 min at 378C. MEFs were then plated and maintained at 378C in an atmosphere of 5% CO 2 in the growing medium [Dulbecco's modified Eagle medium (DMEM); 10% fetal bovine serum (FBS) and penicillin/ streptomycin, Life Technologies]. For adipocyte differentiation, 2-day-postconfluent cells (day 0) were treated for 2 days with differentiation medium (DMEM; 10% FBS and penicillin/streptomycin; 8 mg/ml biotin; 4 mg/ml pantothenate; 10 mg/ml insulin) supplemented with 0.5 mM 3-isobutyl-1-methylxanthine; 1 mM dexamethasone (Sigma-Aldrich). The medium was renewed every 2 days with differentiation medium.
Tissue sections and staining
Embryos were taken at E12.5 and E17.5. After 24 h in 15% sucrose, embryos were embedded in optimal cutting temperature (OCT) embedding matrix (Cell Path), frozen in liquid nitrogen-cooled isopentane and stored at 2808C until processing. Muscles, WAT, heart and liver were taken from P14 Lmna +/+ , Lmna
and Lmna
DK32/DK32
littermates, unless specifically specified. Hearts were stopped in systole by putting the hearts for 1 min in 250 mM KCl. Tissues were embedded in OCT embedding matrix (Cell Path) and frozen in liquid-nitrogen-cooled isopentane and stored at 2808C until processing. Seven micrometer sections were made using a cryostat Leica CM3050S.
Frozen sections and MEFs were stained with HE or Oil Red O stains by standard methods. Immunostainings against myosins were performed using mouse antibodies against fast (My32; Sigma-Aldrich), embryonic or slow myosin heavy chains [F1.652 and A4.840, respectively; developmental studies hybridoma bank (DSHB)] and horseradish peroxydase (HRP)-conjugated anti-mouse antibody. Stainings were developed using diaminobenzidine, mounted with ImmunoMount and visualized using a Nikon Eclipse E600 microscope (Nikon).
Fluorescent immunostaining was performed using primary antibodies against lamin A/C (N18; sc-6215), lamin B1 (C20; sc-6216), SREBP-1 (K10; sc-367), PPARg (H100; sc-7196) (Santa Cruz), followed by incubation with alexafluorconjugated secondary antibodies (Life Technologies), mounted in Vectashield mounting medium with 4 ′ -6-diamidino-2-phenylindole (Vector Laboratories) and visualized using axiophot fluorescent microscope (Carl Zeiss) for postnatal muscle sections, a confocal microscope (Olympus FV-1000) for liver sections and cultured MEF and an inverted confocal microscope (Leica SP2 AOBS AOTF) for embryonic muscle sections.
Protein analysis
Tissue samples were homogenized with FastPrep in protein extraction buffer (50 mM Tris -HCl, pH 7.5; 2% SDS; 250 mM sucrose; 75 mM urea; 1 mM dithiothreitol and with protease/phosphatase inhibitors (25 mg/ml aprotinin, 10 mg/ ml leupeptin; 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride and 2 mM Na 3 VO 4 ).
Protein extracts were separated on sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Millipore). Membranes were blocked in 5% skim milk in tris-buffered saline-Tween 20 and hybridized with rabbit anti-lamin A/C (H110, sc-20681) or anti-SREBP-1 (H160, sc8984), with goat anti-lamin B1 (C20, sc-6216) or anti-prelamin A (C20, sc-6214) (Santa-Cruz) or with mouse anti-a-tubulin or anti-actin antibodies (Sigma-Aldrich) and with secondary anti-rabbit, anti-goat or anti-mouse IgG HRP-conjugated antibodies (Dako). Immunoblots were visualized by Immobilon Western Chemiluminescent HRP Substrate (Millipore) on a G Box system using GeneSnap software (Ozyme).
Quantification of lamin A/C expression level was performed in three to four different samples per genotype and per tissue. The mean normalized ratio of lamin A/C to actin or tubulin (proteins used as loading controls) was measured using the Gene Tools software (Ozyme).
Acylcarnitine analysis
Extraction of acylcarnitines without derivatization involved 10 ml urine mixed with deuterium-labeled internal standards and 1 ml of ice-cold methanol. After hexane washes, the dried supernatant was dissolved in 50% acetonitrile for flow injection analysis in multiple reaction monitoring mode (API 3000; Life Technologies) (45) .
RNA analysis
Total RNA extracts were prepared using RNeasy w Fibrous Tissue Mini Kit (Qiagen) according to the manufacturer's instructions. Two micrograms of total RNA was then reversetranscribed using random hexamers primer with SuperScriptTM III first-strand synthesis system kit for real-time PCR (Life Technologies). Real-time PCR was carried out on a LightCycler w 480, using the LightCycler w 480 SYBR Green I Master (Roche) with sense and anti-sense oligonucleotide primers for the following genes (Supplementary Material, Table S2 ). Relative levels of mRNA expression were calculated according to the DDCT method. Individual expression values were normalized by comparison with Rplp0 mRNA. Values are means + standard deviations. Reactions were performed in triplicate.
Statistical analysis
Data are expressed as mean + standard deviation. Mendelian distribution of the different mouse phenotypes at birth was tested using the x 2 -test, while Student's t-test or MannWhitney rank-sum tests were applied using Sigma Stat software. Statistical significance was assumed at P , 0.05.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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